Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 27 Show results per page	View Search Criteria \| Help With Results

Last Modified: 10/23/2008 First Published: 1/5/2007


1.		Phase I/II Study of Paclitaxel and Ifosfamide Followed By Paclitaxel, Carboplatin, and Ifosfamide With Autologous Peripheral Blood Stem Cell Support in Patients With Cisplatin-Resistant Germ Cell Tumor

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				NCI				MSKCC-06077 NCT00423852


2.		Intracerebral Clysis in Treating Patients With Recurrent Primary Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				1 to 120				Other				R01 CA 89395-01 Topotecan, Brain Tumors, Intracerebral Clysis, NCT00452959


3.		Evaluation of Single Session Stereotactic Body Radiotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				Not specified				Other				2005-0445 NCT00492817

Last Modified: 8/9/2007


4.		Phase II Study of Tandem High-Dose Chemotherapy with Autologous Stem Cell Rescue for Poor Prognosis Germ Cell Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				16 and over				NCI				CHNMC-96126 NCI-G97-1136, NCT00002931

Last Modified: 10/22/2008 First Published: 11/1/1998


5.		Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Severe Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				BC-BT-9 NCT00003457

Last Modified: 10/22/2008 First Published: 11/1/1998


6.		Phase II Study of Antineoplastons A10 and AS2-1 in Adults With Primary Malignant Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				BC-BT-21 NCT00003475


7.		Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				0609-11 IUCRO-0166, AVF4003s, NCT00393861

Last Modified: 8/5/2008 First Published: 5/1/2007


8.		Phase II Study of Combination Chemotherapy and Pegfilgrastim in Patients With Previously Untreated Germ Cell Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				MSKCC-07044 07-044, NCT00470366


9.		Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				GLIA-001 NCT00525590


10.		Ph II Bevacizumab + Etoposide for Pts w Recurrent MG

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Over 18				Other				00000379 NCT00612430

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute